Explore company profiles, quarterly results, announcements and ownership disclosures.
Loading the company view…
Shree Ganesh Remedies Limited (NSE: SGRL), ISIN INE414Y01015 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
SGRL last traded at ₹734.60 (+4.38%), with a 52-week range of ₹381.10 to ₹759.00 (as of 23 Sep 2026).
Shareholding as of Jun 2026: promoters 72.84%, FIIs 0.00%, DIIs 0.52%, mutual funds 0.00%.
EquiSense Score (ECS): 39/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.